ID: ALA387808

Max Phase: Preclinical

Molecular Formula: C34H44N6O8

Molecular Weight: 664.76

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)[C@@H](C)O

Standard InChI:  InChI=1S/C34H44N6O8/c1-18(2)28(35)32(45)38-26(15-20-10-12-22(42)13-11-20)33(46)40-14-6-9-27(40)31(44)37-25(30(43)39-29(19(3)41)34(47)48)16-21-17-36-24-8-5-4-7-23(21)24/h4-5,7-8,10-13,17-19,25-29,36,41-42H,6,9,14-16,35H2,1-3H3,(H,37,44)(H,38,45)(H,39,43)(H,47,48)/t19-,25+,26+,27+,28+,29+/m1/s1

Standard InChI Key:  PNOIHZCNZKBLLY-YQEJDYIASA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 664.76Molecular Weight (Monoisotopic): 664.3221AlogP: 0.55#Rotatable Bonds: 14
Polar Surface Area: 227.18Molecular Species: ACIDHBA: 8HBD: 8
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.68CX Basic pKa: 8.19CX LogP: -1.35CX LogD: -1.41
Aromatic Rings: 3Heavy Atoms: 48QED Weighted: 0.12Np Likeness Score: 0.06

References

1. Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC..  (2007)  Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.,  50  (18): [PMID:17676725] [10.1021/jm070114m]

Source